Videos de Experimentos Relacionados
¿Puede el DOTS controlar la tuberculosis multirresistente a los medicamentos?
Marcos A Espinal1, Christopher Dye
1Stop TB Partnership, World Health Organization, CH-1211 Geneva, Switzerland. espinalm@who.int
Lancet (London, England)
|April 7, 2005
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Long term monitoring and adaptive strategies: lessons from Hainan's malaria elimination and prevention efforts.
BMJ (Clinical research ed.)·2025
Same author
PAHO is Latin America's Centre for Disease Control and Prevention.
Lancet (London, England)·2025
Same author
Dynamics of SARS-CoV-2 infection over two epidemic waves in Manaus, Brazil: A serological study of seven thousand blood donors.
PloS one·2025
Same author
Effectiveness of the primary Bacillus Calmette-Guérin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant data.
The Lancet. Microbe·2024
Same author
Effectiveness of face masks for reducing transmission of SARS-CoV-2: a rapid systematic review.
Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2023
Same journal
Convergence of metabolic risk in obesity and normal BMI: does risk disappear?
Lancet (London, England)·2026
Same journal
Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.
Lancet (London, England)·2026
Same journal
Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.
Lancet (London, England)·2026
Same journal
The US Ebola response and the future of global health leadership.
Lancet (London, England)·2026
Same journal
The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?
Lancet (London, England)·2026